This post was originally published on this site
The company said the business, which brought in $8.6 billion in sales in 2021, will focus on wound care, oral care and healthcare technology.
It expects to complete the transaction by end of 2023.
The diversified manufacturer on Tuesday reported a fall in second-quarter adjusted profit as COVID-19 lockdowns in China impacted the company’s manufacturing operations in the country.
3M’s adjusted profit fell to $2.48 per share from $2.75 per share a year earlier.
